AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Sitapep M 50/500 Tablet

Prescription Icon
Prescription Required

Marketer

Mexican Wave Pharma

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitapep M 50/500 Tablet

Diabetol Duo 50/500 tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent serious diabetic complications, such as vision loss and kidney disease, and may lessen the risk of stroke or heart attack. Diabetol Duo 50/500 may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized based on your health status, blood sugar readings, and existing medications. Taking it with food minimizes stomach upset. Consistent daily dosing at the same time maximizes efficacy; discontinuation should only occur under physician guidance. Adherence to your prescribed diet and exercise plan is crucial for effective diabetes control. Common side effects include nausea, diarrhea, vomiting, stomach discomfort, headache, and sore throat. Low blood sugar (hypoglycemia) is a potential side effect, particularly when combined with insulin or sulfonylureas; learn to recognize and manage this. This medication isn't suitable for everyone. Inform your doctor of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption before commencing treatment. Pregnant or breastfeeding individuals should seek medical advice. Other medications may interact with Diabetol Duo 50/500; disclose all medications to your physician to ensure safety. Alcohol should be limited due to its potential to lower blood glucose. Your doctor will monitor your kidney function and blood glucose levels throughout treatment.

Uses of Sitapep M 50/500 Tablet

Managing type 2 diabetes

Major Benefits of Sitapep M 50/500 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitapep M 50/500 Tablet whole; do not crush, chew, or divide it. Administer this medication with a meal.

Common Side effects of Sitapep M 50/500 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitapep M 50/500 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitapep M 50/500 Tablet whole; do not break, crush, or chew it. Administer this medication with food.

How Sitapep M 50/500 Tablet works:

Sitapep M 50/500, a dual-action tablet containing sitagliptin and metformin, improves blood glucose management. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and increasing insulin sensitivity. This combined action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitapep M 50/500 Tablet and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitapep M 50/500 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Consult your doctor for advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitapep M 50/500 tablets while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitapep M 50/500 Tablets cautiously, potentially requiring dosage modification. Consult your physician. Sitapep M 50/500 Tablets are contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

Use of Sitapep M 50/500 Tablet is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Sitapep M 50/500 Tablet :

Should you forget a dose of Sitapep M 50/500 Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitapep M 50/500 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitapep M 50/500 Tablet

Sitapep M 50/500 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged Sitapep M 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, neurological issues (including numbness, tingling in extremities, weakness, and ataxia), and urinary problems, potentially affecting mental status. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Sitapep M 50/500 Tablet may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Sitapep M 50/500 Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitapep M 50/500 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (Sitapep M 50/500) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Sitapep M 50/500 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitapep M 50/500 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Sitapep M 50/500 Tablets are contraindicated in patients with known allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitapep M 50/500 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (like Sitapep M 50/500) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also called Metformin-Associated Lactic Acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Sitapep M 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitapep M 50/500 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. It helps control blood sugar when used with diet and exercise. Metformin reduces liver glucose production and improves insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitapep M 50/500 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Sitapep M 50/500 Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitapep M 50/500 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitapep M 50/500 Tablets can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitapep M 50/500 and seek immediate medical attention.
Prolonged Sitapep M 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitapep M 50/500 Tablet
85
MRP 99
14% off